Follow The Filings

KEQU Kewaunee Scientific

Kewaunee Scientific earnings company data as of 4:51 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 9 Dec EPS — — —
Rev — — —
FY2027 Q1 9 Sep EPS — 0.58 —
Rev — $66.3M —

Insider trades

Open-market buys and sales by KEQU's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KEQU insider trades
  • None no insider bought on the open market
  • $293K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Thomas David Hull III CEO
    Sale
    $82K 2,177 shares at $37.50 6.2% of stake
    Traded Jan 7 Filed Jan 8
  2. Donald T. Gardner III CFO
    Sale
    $75K 2,000 shares at $37.57 17% of stake
    Traded Jan 6 Filed Jan 7
  3. Thomas David Hull III CEO
    Sale
    $25K 658 shares at $37.67 1.8% of stake
    Traded Dec 30–31 Filed Jan 2
  4. Thomas David Hull III CEO
    Sale
    $34K 884 shares at $38.01 2.4% of stake
    Traded Dec 29, 2025 Filed Dec 31, 2025
  5. Thomas David Hull III CEO
    Sale
    $39K 1,000 shares at $39.00 2.7% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
  6. Thomas David Hull III CEO
    Sale
    $39K 1,000 shares at $39.00 2.6% of stake
    Traded Dec 17, 2025 Filed Dec 17, 2025
  7. Donald T. Gardner III CFO
    Sale
    $128K 3,000 shares at $42.76 21% of stake
    Traded Oct 9, 2025 Filed Oct 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 6 sales back to the company, 6 share withholdings for taxes, 6 option exercises, 2 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 5.07
8-K 7.01,9.01
8-K 8.01,9.01
DEF 14A
DEFA14A
SCHEDULE 13G/A —
10-K
8-K 2.02,9.01
8-K 8.01,9.01
10-Q
8-K 2.02,9.01
8-K 8.01,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 1.01,1.02,2.03,7.01,9.01
8-K 8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.